Theravance Biopharma Inc (TBPH)
9.60
-0.13
(-1.34%)
USD |
NASDAQ |
Dec 20, 16:00
9.45
-0.15
(-1.56%)
After-Hours: 20:00
Theravance Biopharma Market Cap: 472.07M for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics Inc | 5.389B |
| Madrigal Pharmaceuticals Inc | 6.733B |
| Ionis Pharmaceuticals Inc | 5.627B |
| Jazz Pharmaceuticals PLC | 7.436B |
| NovaBay Pharmaceuticals Inc | 2.589M |
Market Cap Related Metrics
| PS Ratio | 7.422 |
| PEG Ratio | -1.505 |
| Price to Book Value | 2.543 |
| Price | 9.60 |
| Earnings Yield | -10.52% |
| PEGY Ratio | -1.505 |